anti-psychotic drugs

iloperidone's efficacy and safety

harminka — Thu, 08 May 2008 00:11:02 -0500

Data presented today on Vanda Pharmaceuticals Inc.'s (NASDAQ: VNDA) investigational drug candidate, iloperidone, included its 4-week, short-term Phase III trial, as well as a pooled analysis of three long-term, 52-week trials, studying the efficacy and safety of iloperidone.

Antipsychotic Drugs Increase Risk of Developing Pneumonia in Elderly

harminka — Tue, 15 Apr 2008 12:04:58 -0500

Elderly patients who use antipsychotic drugs have a 60 percent increased risk of developing pneumonia compared to non-users. This risk is highest in the first week following prescription and decreases gradually thereafter. These findings are published in Journal of the American Geriatrics Society.

New anti-psychotic drugs no better than older, cheaper ones

harminka — Mon, 04 Dec 2006 15:02:41 -0600